U.S. Drug Authorities Seen Sidelined by Biden’s Booster Push (1)

Aug. 18, 2021, 9:26 PM

The White House’s plan to begin offering booster shots next month to almost all vaccinated U.S. adults is raising concerns among health experts that the administration is rushing ahead without enough data and regulatory oversight.

On Wednesday as expected, officials from the U.S. Food and Drug Administration, the Centers for Disease Control and Prevention, along with the U.S. Surgeon General and White House Covid-19 adviser Anthony Fauci, announced the booster plan. But it came without the FDA and CDC publicly saying they had fully vetted giving a third shot to the 100 million fully-vaccinated Americans by year’s end.

Messenger ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.